Source item
Open original source ↗I am 100% in agreement with @linakhanFTC on this one. Extending patents with bullshit mechanics is not open competition. And knowingly charging 75x more for something in the US than another country is blasphemous. Even the adjusted settlement is 500% than outside US.
Quoted context
These are the quoted author’s words.
FTC Chair Lina Khan shows Lesley Stahl an asthma inhaler that costs dollars in Europe but hundreds in the U.S. She says drugmakers register patents on inhaler parts like the cap-strap to keep low-cost generics off the market. https://t.co/xfxUTrGrFB https://t.co/YUWH4PKkCn
60Minutes ↗